Halberd Co. (OTCMKTS:HALB – Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 189,400 shares, an increase of 272.8% from the January 31st total of 50,800 shares. Based on an average daily volume of 2,811,300 shares, the […]
Halberd Co. (OTCMKTS:HALB – Get Free Report) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 206,900 shares, a growth of 61.0% from the December 31st total of 128,500 shares. Based on an average daily trading volume, of 6,831,400 shares, the short-interest ratio is presently 0.0 […]
Halberd Co. (OTCMKTS:HALB – Get Free Report) was the recipient of a large growth in short interest in August. As of August 15th, there was short interest totalling 10,600 shares, a growth of 10,500.0% from the July 31st total of 100 shares. Based on an average trading volume of 1,340,900 shares, the days-to-cover ratio is […]
Halberd (OTCMKTS:HALB – Get Free Report) is one of 385 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Halberd to related businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Valuation & Earnings This table compares […]
Halberd (OTCMKTS:HALB – Free Report) is one of 361 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to related companies based on the strength of its risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends. Institutional and Insider Ownership 22.1% of shares […]